Laurent Tessonnier
Toulon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 29, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Journal: The Lancet. Oncology
Published: March 14, 2024
Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non-Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy.
Journal: JCO precision oncology
Published: November 01, 2020
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
Journal: JAMA oncology
Published: September 08, 2018
Rapid clearance of circulating tumor DNA during treatment with AZD9291 of a lung cancer patient presenting the resistance EGFR T790M mutation.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 31, 2015
Atypical measles syndrome in adults: still around.
Journal: BMJ case reports
Published: September 25, 2015
Letter on the article: "senile systemic amyloidosis: definition, diagnosis, why thinking about?"
Journal: Presse medicale (Paris, France : 1983)
Published: August 09, 2013
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 07, 2013
Rosai-Dorfman disease initially misdiagnosed as sarcoidosis.
Journal: Arthritis and rheumatism
Published: January 03, 2013
99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
Journal: Clinical nuclear medicine
Published: July 13, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026